98 related articles for article (PubMed ID: 28843380)
1. The impact of intensity-modulated radiation therapy plan normalization in the postprostatectomy setting-does it matter?
Stritch MA; Forde E; Leech M
Med Dosim; 2017 Winter; 42(4):368-374. PubMed ID: 28843380
[TBL] [Abstract][Full Text] [Related]
2. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
[TBL] [Abstract][Full Text] [Related]
5. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
Liu F; Ahunbay E; Lawton C; Li XA
Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
[TBL] [Abstract][Full Text] [Related]
6. A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.
Shah AP; Chen SS; Strauss JB; Kirk MC; Coleman JL; Coon AB; Miller C; Dickler A
Am J Clin Oncol; 2009 Oct; 32(5):460-6. PubMed ID: 19564784
[TBL] [Abstract][Full Text] [Related]
7. A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer.
Chitapanarux I; Tharavichitkul E; Nobnop W; Wanwilairat S; Vongtama R; Traisathit P
J Radiat Res; 2015 May; 56(3):539-45. PubMed ID: 25720771
[TBL] [Abstract][Full Text] [Related]
8. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
9. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
[TBL] [Abstract][Full Text] [Related]
10. Defining the "Hostile Pelvis" for Intensity Modulated Radiation Therapy: The Impact of Anatomic Variations in Pelvic Dimensions on Dose Delivered to Target Volumes and Organs at Risk in Patients With High-Risk Prostate Cancer Treated With Whole Pelvic Radiation Therapy.
Yirmibeşoğlu Erkal E; Karabey S; Karabey A; Hayran M; Erkal HŞ
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):894-903. PubMed ID: 26104941
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
13. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.
Stanley DN; Popp T; Ha CS; Swanson GP; Eng TY; Papanikolaou N; Gutiérrez AN
Pract Radiat Oncol; 2015; 5(6):e625-33. PubMed ID: 26419443
[TBL] [Abstract][Full Text] [Related]
15. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
[TBL] [Abstract][Full Text] [Related]
16. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
Moore KL; Brame RS; Low DA; Mutic S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays.
Hayashi A; Shibamoto Y; Hattori Y; Tamura T; Iwabuchi M; Otsuka S; Sugie C; Yanagi T
J Radiat Res; 2015 Mar; 56(2):338-45. PubMed ID: 25609741
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
[TBL] [Abstract][Full Text] [Related]
19. Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.
Guckenberger M; Pohl F; Baier K; Meyer J; Koelbl O; Flentje M; Vordermark D
Strahlenther Onkol; 2006 Dec; 182(12):721-6. PubMed ID: 17149579
[TBL] [Abstract][Full Text] [Related]
20. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
